Table 4.
Polyphenol | Cell Line | Concentration/ Duration |
Anti-Cancer Effects | Type IV Collagenase-Mediated Mechanisms | Reference |
---|---|---|---|---|---|
EGCG [(2 R,3 R)-3′,4′,5,5′,7-pentahydroxyflavan-3-yl 3,4,5-trihydroxybenzoate] |
DU-145 | 2, 5, 10, 20, 40 μg/mL for 24 h | not specified | ↓MMP-2, -9 secretion, activity ↓NF-κB ↓ERK-1/-2 ↓p38 |
[46] |
786-O | 10, 50, 100, 200 μg/mL for 24 h with or without PMA treatment | not specified | ↓MMP-2, -9 activity | [53] | |
HeLa DoTc2-4510 SK-OV-3 |
10, 25, 50, 100 μM for 24 h with or without PMA treatment |
not specified | ↓MMP-2 activity (HeLa, SK-OV-3) ↓MMP-9 activity (HeLa, DoTc2-4510) |
[52] | |
SCC-9 | 5, 10, 15, 20 μM for 24 h with or without PMA treatment |
↓cell migration ↓cell invasion |
↓MMP-2 mRNA, protein, activity ↓MMP-9 activity ↑TIMP-2 mRNA, protein ↓NF-κB protein |
[62] | |
CL1-5 | 5, 10, 20, 30, 40, 50 μM for 9, 12, 16, 24 h | ↓cell migration ↓cell invasion |
↓MMP-2 mRNA, protein, activity, promoter activity ↓MMP-9 mRNA, protein, activity ↓NF-κB nuclear translocation |
[60] | |
SW-1353, HT-1080, SW-872, SW-982 | 10, 25, 50, 100 μM for 24 h with or without PMA treatment |
not specified | ↓MMP-2, -9 activity | [51] | |
U2 OS RD |
10, 25, 50, 100 μM for 24 h with or without PMA treatment |
not specified | ↓MMP-2 activity ↓MMP-9 activity |
[50] | |
TW01 (EBV-negative) NA (EBV-positive, reinfected TW01) |
10, 20, 30, 50 μM for 9, 12, 24, 48 h (cells) 1, 2.5, 5, 10, 25 μM for 7 days (spheroid) |
↓spheroid formation ↓cell migration ↓cell invasion ↓proliferation |
↓MMP-2 mRNA, activity ↓MMP-9 activity ↓pERK-1/-2 protein |
[61] | |
786-O ACHN |
10, 20, 40 μg/mL for 24 h | ↓cell migration ↓cell invasion |
↓MMP-2, -9 activity, protein | [55] | |
HuCC-T1 | 0.1, 0.5, 1, 5, 10, 20, 50 μg/mL for 24 h | ↓cell migration ↓cell invasion ↑apoptosis |
↓MMP-2 activity ↓MMP-9 activity |
[56] | |
SW780 | 12.5, 25, 50, 100 μM for 24 h | ↓cell invasion ↓cell migration ↓proliferation ↑apoptosis |
↓MMP-9 mRNA, protein ↓pNF-κB p65 protein ↓NF-κB mRNA |
[57] | |
A-2058 | 10, 25, 50, 100 μM for 24 h | not specified | ↓MMP-2, -9 activity | [48] | |
FaDu SCC-25 |
10, 25, 50, 100 μM for 24 h with or without PMA treatment |
not specified | ↓MMP-2, -9 activity | [49] | |
NPC-39 HONE-1 NPC-BM |
6, 12, 25, 50 μM for 12, 24 h | ↓cell migration ↓cell invasion |
↓MMP-2 activity, protein | [54] | |
A549 H1299 |
20, 80, 160 μM for 24, 48 h or 20 μM with 0,625, 1.25, 2.5, 5 μM of BAY11-7082 for 24, 48 h |
↓proliferation ↑apoptosis ↓cell invasion ↓cell migration |
↓MMP-2 mRNA ↓NF-κB, pNF-κB mRNA, protein |
[59] | |
A549 H1299 |
12.5, 25 μM for 48 h (free EGCG or PLGA-encapsulated EGCG) | ↓proliferation ↑apoptosis |
↓MMP-2 mRNA ↓NF-κB, pNF-κB protein |
[58] |
Legend: ↑ activation or increase; ↓ inhibition or decrease.